Using tumor cells transduced with ICOSL as a vaccine, the authors observed improved effects of antitumor T effector cells, which is reflected by a higher ratio of intratumoral CD8/Treg and CD4+ Teff/Treg cell. The gene discussed is CD8A; the disease is neoplasm.